Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma.

I've learned to embrace the changing nature of my body as I age, accepting the challenges and finding gratitude in each day.

From tennis star Gabriela Dabrowski sharing details of her breast cancer journey to Greg Gumbel and Linda Lavin dying, here ...

An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade ...

An expert explained recent findings from a study of pregnant women with breast cancer who underwent chemotherapy and fared ...

A panelist discusses how polycythemia vera (PV) symptoms can vary significantly among patients, but commonly include headaches, dizziness, itching (especially after warm baths), fatigue and visual ...

Despite being declared cancer-free after initial treatment, I grapple with survivor's guilt, questioning why my lymphoma ...

One research noted the persistent efforts to develop new treatments for myeloproliferative neoplasms (MPNs), a commitment ...

SOXRC Regimen Improves Responses Versus Chemo Alone in Advanced Gastric Cancers ...

While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading ...

A patient with MPN urges others to ask questions about treatment options, which may also include inquiring about clinical ...

As I prepare for treatment of my chronic lymphocytic leukemia, I reflect on the challenges of aging and side effects while ...